Marshalling Bio-IT in the Name of Preparedness

Discerning whether a biological threat comes from terrorism or an emerging infectious disease is one problem that researchers at the Courant Bioinformatics Group at New York University (NYU) want to solve. Bhubaneswar Mishra's multidisciplinary team has created a series of complex software programs that allow researchers who deal with intricate, real-world bioinformatics problems to develop their own algorithms. This allows them to use mathematics to solve real issues in biology.With one interac

Written byMyrna Watanabe
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Discerning whether a biological threat comes from terrorism or an emerging infectious disease is one problem that researchers at the Courant Bioinformatics Group at New York University (NYU) want to solve. Bhubaneswar Mishra's multidisciplinary team has created a series of complex software programs that allow researchers who deal with intricate, real-world bioinformatics problems to develop their own algorithms. This allows them to use mathematics to solve real issues in biology.

With one interactive part of the software called Valis, "biologists can cobble applications together rapidly" to build new tools in record time, explains Raoul-Sam Daruwala, a research computer scientist at Courant.

A second tool, called Simpathica, creates "an environment for exploring issues in systems biology," says Daruwala. With Simpathica, researchers can draw biological pathways of interactions between genes and proteins, proteins and proteins, and other biological molecules, thus facilitating hypothesis testing in silico.

These programs will give biologists simple ways ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies